Ibuakut

Ibuprofen, the active ingredient in Ibuakut, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral tablet of unspecified strength for oral use. It is employed to relieve pain, reduce fever and diminish inflammation associated with conditions such as arthritis, musculoskeletal injuries and common colds.

GNH USA supplies Ibuakut as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Our supply chain ensures product integrity from manufacturing to end‑user delivery.

Ibuprofen is an NSAID that reduces pain, fever and inflammation by inhibiting prostaglandin synthesis.

- Pain: provides analgesia for mild to moderate pain such as headache, dental or musculoskeletal discomfort. - Fever: lowers elevated body temperature in acute febrile states. - Inflammation: decreases swelling and stiffness in conditions like osteoarthritis and rheumatoid arthritis.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness: transient light‑headedness. - Rash: mild skin irritation or erythema.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Acute renal impairment, especially in volume‑depleted patients. - Severe allergic reactions such as anaphylaxis. - Hepatic enzyme elevation or hepatitis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiovascular events including myocardial infarction in high‑risk individuals.

Before initiating ibuprofen therapy, consider the following safety measures.

- Renal function: assess baseline kidney status and avoid use in severe impairment. - Gastrointestinal risk: use the lowest effective dose in patients with a history of ulcers or bleeding. - Pregnancy: avoid in the third trimester due to fetal cardiovascular risks. - Concomitant NSAIDs: do not combine with other non‑steroidal anti‑inflammatory drugs. - Dose limitation: employ the minimum effective dose for the shortest duration needed. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Ibuprofen can alter the pharmacokinetics or pharmacodynamics of several medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Lithium: reduced renal clearance leading to toxicity. - Methotrexate: decreased elimination and heightened toxicity.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): additive bleeding risk. - ACE inhibitors or ARBs: possible reduction in antihypertensive effect and renal function.